Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
|
| Revenues: | ||||
| Total revenues, net | $ 1,110,794 | $ 2,201,232 | $ 5,202,423 | $ 6,169,543 |
| Operating expenses: | ||||
| Cost of product sales | 76,636 | 132,382 | 220,775 | |
| Cost of product sales | (611,747) | |||
| Research and development | 8,871,574 | 1,743,435 | 19,556,194 | 8,857,220 |
| Acquired in-process research and development | 0 | 0 | 25,549,344 | 0 |
| General and administrative | 4,573,292 | 2,638,023 | 13,350,380 | 7,654,266 |
| Sales and marketing | 462,318 | 214,207 | 1,792,108 | 936,343 |
| Amortization expense | 403,500 | 334,748 | 1,237,583 | 1,004,243 |
| Change in fair value of contingent consideration | 0 | 0 | 0 | (1,256,210) |
| Total operating expenses | 14,387,320 | 5,062,795 | 61,706,384 | 16,584,115 |
| Loss from continuing operations | (13,276,526) | (2,861,563) | (56,503,961) | (10,414,572) |
| Other income: | ||||
| Change in fair value of Investment in Aytu | 0 | 0 | 5,207,789 | 0 |
| Other income, net | 18,668 | 52,711 | 446,897 | 83,273 |
| Total other income, net from continuing operations | 18,668 | 52,711 | 5,654,686 | 83,273 |
| Loss from continuing operations before taxes | (13,257,858) | (2,808,852) | (50,849,275) | (10,331,299) |
| Income tax expense (benefit) | 3,282 | 121,640 | (2,607,530) | 305,759 |
| Loss from continuing operations | (13,261,140) | (2,930,492) | (48,241,745) | (10,637,058) |
| (Loss) income from discontinued operations, net of tax | (197,505) | (1,085,962) | 384,690 | (7,056,543) |
| Net loss | (13,458,645) | (4,016,454) | (47,857,055) | (17,693,601) |
| Product revenue, net | ||||
| Revenues: | ||||
| Total revenues, net | 1,110,794 | 2,101,232 | 5,202,423 | 6,069,543 |
| License and other revenue | ||||
| Revenues: | ||||
| Total revenues, net | $ 0 | $ 100,000 | $ 0 | $ 100,000 |
| Common stock | ||||
| Earnings Per Share [Abstract] | ||||
| Continuing operations (in dollars per share) | $ (0.16) | $ (0.05) | $ (0.68) | $ (0.19) |
| Discontinued operations (in dollars per share) | (0.01) | (0.02) | 0.00 | (0.12) |
| Net loss per share, basic and diluted (in dollars per share) | (0.17) | (0.07) | (0.68) | (0.31) |
| Preferred Stock | ||||
| Earnings Per Share [Abstract] | ||||
| Continuing operations (in dollars per share) | (0.82) | (0.26) | (3.40) | (0.94) |
| Discontinued operations (in dollars per share) | (0.01) | (0.09) | 0.02 | (0.62) |
| Net loss per share, basic and diluted (in dollars per share) | $ (0.83) | $ (0.35) | $ (3.38) | $ (1.56) |
| X | ||||||||||
- Definition Cost Of Goods And Services Sold, Net Of Settlement No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per basic and diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation, when the per share amount is the same. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares. No definition available.
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. No definition available.
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|